Both in Biotechnology
Tarsus Pharmaceuticals vs ADMA Biologics
Over the past year TARS returned +4.1% and ADMA returned −27.7%; their daily moves had a correlation of 0.19.
TARS +4.1% ADMA −27.7%Growth of $1, one year, split-adjusted
| Metric | TARS | ADMA |
|---|---|---|
| Price | $72.64 | $11.11 |
| Market cap | $3.40B | $2.49B |
| Today | −0.93% | +0.45% |
| 1 month | −2.4% | +9.9% |
| 6 months | +11.7% | +8.4% |
| Year to date | −11.3% | −39.1% |
| 1 year | +5.6% | −28.2% |
| Revenue growth (YoY) | +69.4% | +2.0% |
| Gross margin | 93.0% | 69.4% |
| Net margin | −10.7% | 30.4% |
| P/E (TTM) | — | 14.7× |
| Price / sales | 5.6× | 4.9× |
| Net cash | $376.9M | -$60.6M |
| Dividend yield | — | — |
| Volatility (60d) | 46.1% | 38.5% |
| Short % of float | 15.3% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).